Arjun Agarwal - Net Worth and Insider Trading

Arjun Agarwal Net Worth

The estimated net worth of Arjun Agarwal is at least $1 Million dollars as of 2026-09-21. Arjun Agarwal is the Senior Vice President, Finance of Oruka Therapeutics Inc and owns about 14,752 shares of Oruka Therapeutics Inc (ORKA) stock worth over $1 Million. Details can be seen in Arjun Agarwal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arjun Agarwal has not made any transactions after 2026-09-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Arjun Agarwal

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Arjun Agarwal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Arjun Agarwal owns 1 companies in total, including Oruka Therapeutics Inc (ORKA) .

Click here to see the complete history of Arjun Agarwal’s form 4 insider trades.

Insider Ownership Summary of Arjun Agarwal

Ticker Company Transaction Date Type of Owner
ORKA Oruka Therapeutics Inc 2026-09-15 SVP & Finance

Arjun Agarwal Latest Holdings Summary

Arjun Agarwal currently owns a total of 1 stock. Arjun Agarwal owns 14,752 shares of Oruka Therapeutics Inc (ORKA) as of September 15, 2026, with a value of $1 Million.

Latest Holdings of Arjun Agarwal

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ORKA Oruka Therapeutics Inc 2026-09-15 14,752 94.97 1,400,997

Holding Weightings of Arjun Agarwal


Arjun Agarwal Form 4 Trading Tracker

According to the SEC Form 4 filings, Arjun Agarwal has made a total of 7 transactions in Oruka Therapeutics Inc (ORKA) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Oruka Therapeutics Inc is the sale of 10,019 shares on September 15, 2026, which brought Arjun Agarwal around $926,056.

Insider Trading History of Arjun Agarwal

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Arjun Agarwal Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Arjun Agarwal owns.
View ORKA Analysis

Arjun Agarwal Ownership Network

Ownership Network List of Arjun Agarwal

No Data

Ownership Network Relation of Arjun Agarwal

Insider Network Chart


Arjun Agarwal Owned Company Details

What does Oruka Therapeutics Inc do?

Who are the key executives at Oruka Therapeutics Inc?

Arjun Agarwal is the SVP & Finance of Oruka Therapeutics Inc. Other key executives at Oruka Therapeutics Inc include Chief Medical Officer Joana Goncalves , General Counsel Paul T Quinlan , and director & Chief Executive Officer Lawrence Otto Klein .

Oruka Therapeutics Inc (ORKA) Insider Trades Summary

Over the past 18 months, Arjun Agarwal made 7 insider transaction in Oruka Therapeutics Inc (ORKA) with a net sale of 52,144. Other recent insider transactions involving Oruka Therapeutics Inc (ORKA) include a net sale of 72,535 shares made by Joana Goncalves , a net sale of 35,106 shares made by Laura Lee Sandler , and a net sale of 80,910 shares made by Lawrence Otto Klein .

In summary, during the past 3 months, insiders sold 3,748,359 shares of Oruka Therapeutics Inc (ORKA) in total and bought 0 shares, with a net sale of 3,748,359 shares. During the past 18 months, 3,988,610 shares of Oruka Therapeutics Inc (ORKA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,988,610 shares.

Oruka Therapeutics Inc (ORKA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oruka Therapeutics Inc Insider Transactions

No Available Data

Arjun Agarwal Mailing Address

Above is the net worth, insider trading, and ownership report for Arjun Agarwal. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Arjun Agarwal's mailing address is: Menlo Park Ca 94025.